Hims & Hers Health has seen massive success, aided by the growing use of GLP-1 drugs. Click here to find out why I downgrade ...

Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...

Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.

By Bhanvi Satija NEW YORK (Reuters) -Telehealth platform Hims & Hers said on Tuesday it will acquire London-based startup ...

HIMS showcases outstanding financial strength. With just $63 million in debt against a market value of $13 billion, the ...

The cash-based acquisition – the financial terms of which are not being disclosed – will expand Hims & Hers' presence in the ...

The direct-to-consumer telehealth company said the workforce reduction is unrelated to its weight-loss drug sector.

Hims & Hers Health, Inc. navigates strong growth and partnerships despite rising competitive risks. Click here to read an ...

Telehealth platform Hims & Hers will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S. ban on ...

Hims to cut 4% of workforce amid ban on weight ... cancer risks Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related cancers ...

Just 14 stocks with market caps above $1 billion have doubled so far this year. They probably aren't the winners you would ...

Tuesday, online health and wellness company Hims & Hers announced its intent to acquire European digital healthcare provider ...